First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome
Authors:
- 12 October 2012
- journal article
- review article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 28 (1) , 3-12
Abstract
The first trimester screening programme offers a noninvasive option for the early detection of aneuploidy pregnancies. This screening is done by a combination of two biochemical markers i.e. serum free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein A (PAPP-A), maternal age and fetal nuchal translucency (NT) thickness at 11 + 0–13 + 6 weeks of gestation. A beneficial consequence of screening is the early diagnosis or trisomies 21, 18 and 13. At 11 + 0–13 + 6 weeks, the relative prevalence of trisomies 18 and 13 to trisomy 21 are found to be one to three and one to seven, respectively. All three trisomies are associated with increased maternal age, increased fetal NT and decreased PAPP-A, but in trisomy 21 serum free β-hCG is increased whereas in trisomies 18 and 13 free β-hCG is decreased.Keywords
This publication has 47 references indexed in Scilit:
- Extragonadal actions of chorionic gonadotropinReviews in Endocrine and Metabolic Disorders, 2011
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free -hCG and pregnancy-associated plasma protein-AHuman Reproduction, 2008
- Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populationsPrenatal Diagnosis, 2005
- First-trimester Screening: An OverviewJournal of Histochemistry & Cytochemistry, 2005
- Low Pregnancy-Associated Plasma Protein-A at 10+1 to 14+6 Weeks of Gestation and a Possible Mechanism Leading to MiscarriageFetal Diagnosis and Therapy, 2004
- Antenatal screening for Down's syndrome with the quadruple testThe Lancet, 2003
- Complex of Pregnancy-associated Plasma Protein-A and the Proform of Eosinophil Major Basic ProteinJournal of Biological Chemistry, 2003
- Messenger Ribonucleic Acid Levels of Pregnancy-Associated Plasma Protein-A and the Proform of Eosinophil Major Basic Protein: Expression in Human Reproductive and Nonreproductive Tissues1Biology of Reproduction, 1999
- Maternal age‐ and gestation‐specific risk for trisomy 21Ultrasound in Obstetrics & Gynecology, 1999
- Non-echogenic nuchal oedema as a marker in trisomy 21 screeningThe Lancet, 1992